Amid Medicare Uncertainty, Biogen Offers Its Alzheimer’s Drug For Free
Biogen Inc (NASDAQ:BIIB) is providing its controversial and expensive new Alzheimer’s drug, free of charge for some patients amid…
Expert Ratings For Biogen
Biogen (NASDAQ:BIIB) has observed the following analyst ratings within the last quarter:
Last 30 Days
1 Month Ago
2 Months Ago
White House Dismisses Janet Woodcock As Permanent FDA Commissioner Candidate: Bloomberg
The Biden Administration has ruled out the nomination of acting FDA commissioner Janet Woodcock as permanent head of…
Controversial Aduhelm To Administered At More Than 300 Hospitals: Nikkei’s
Eisai Co Ltd (OTC:ESALY) and its U.S. partner Biogen Inc’s (NASDAQ:BIIB) Alzheimer’s treatment Aduhelm (aducanumab) will be used by more than 300 American…
Q2 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios
The latest round of 13F filings from institutional investors is out, revealing to the world the stocks that some of the richest and most successful investors have been buying and selling.
‘Eisai-Biogen Alzheimer’s drug set for use at 300-plus US hospitals: exec’ -Nikkei
https://asia.nikkei.com/Business/Pharmaceuticals/Eisai-Biogen-Alzheimer-s-drug-set-for-use-at-300-plus-US-hospitals-exec
Apple, GM, Kroger, AbbVie, Merck, Bristol Myers Squibb, Biogen — How Warren Buffett’s Berkshire Adjusted Its Portfolio In Q2
Warren Buffett-led Berkshire Hathaway Inc (NYSE: BRK-A) (NYSE: BRK-B) sharply lowered its exposure in General Motors Co (NYSE:
Novavax Appoints New CFO Amid Inordinate Delay In COVID-19 Vaccine Authorization
Novavax, Inc. (NASDAQ: NVAX) announced new hires to its executive team even as it is stymied by the delay in getting authorization for its COVID-19 vaccine in the U.S.
Biogen’s New Alzheimer’s Drug Turned Away By Veterans Affairs
The Department of Veterans Affairs (VA) has decided not to include the new Alzheimer’s drug developed by Biogen Inc (NASDAQ:BIIB)…